GE Healthcare announces FDA 510(k) clearance of SenoBright CESM for breast cancer diagnosis

GE Healthcare announces FDA 510(k) clearance of SenoBright CESM for breast cancer diagnosis
2.5 5

Post new comment

The content of this field is kept private and will not be shown publicly.